Impact of Nicotine Messaging on Nicotine Beliefs and Tobacco Use Behavior
2 other identifiers
interventional
794
1 country
1
Brief Summary
This is a 2-arm, randomized controlled, population based trial to test the impact of multiple exposures to brief nicotine corrective messages among adult tobacco cigarette smokers and non-smokers followed in waves over 12 weeks. The primary outcome, assessed at wave 1 (baseline), wave 2 (weeks 5-6), and wave 4 (weeks 11-13) is nicotine beliefs. Secondary outcomes assessed at the same time points include intention to use nicotine/tobacco products and nicotine/tobacco use.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 11, 2021
CompletedStudy Start
First participant enrolled
February 12, 2021
CompletedFirst Posted
Study publicly available on registry
March 18, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2021
CompletedResults Posted
Study results publicly available
December 2, 2022
CompletedDecember 2, 2022
November 1, 2022
4 months
February 11, 2021
September 27, 2022
November 15, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Nicotine Beliefs
3 items assessing nicotine false beliefs (range 3-11), 6 items assessing nicotine replacement therapy (NRT) false beliefs (range 4-20), 4 items assessing e-cigarette false beliefs (range 2-14), 11 items assessing reduced nicotine content (RNC) cigarette false beliefs (range 14-45), and two items assessing beliefs about additive-free and organic tobacco products. Higher scale scores indicate a higher number of false beliefs.
Wave 4 (weeks 11-13)
Secondary Outcomes (2)
Intention to Use Nicotine/Tobacco Products
Wave 4 (weeks 11-13)
Tobacco Use
Wave 4 (weeks 11-13)
Other Outcomes (3)
Attitudes About Nicotine
Wave 4 (weeks 11-13)
Nicotine Related Norms
Wave 4 (weeks 11-13)
Behavioral Control
Wave 4 (weeks 11-13)
Study Arms (2)
Nicotine Corrective Messages
EXPERIMENTALParticipants in the nicotine corrective messages condition will receive 8 brief nicotine corrective public education messages delivered online during 4 waves of the 12 week study. The messages will communicate misperceptions about nicotine's role in health harms as well as misperceptions that reduced nicotine content cigarettes are less harmful than tobacco cigarettes and that e-cigarettes contain less nicotine than tobacco cigarettes.
Delayed Message Control
NO INTERVENTIONParticipants in the control condition will be exposed to the nicotine corrective messages after the completion of the final assessment at the end of the 12 week study.
Interventions
Messages communicating misperceptions of nicotine's role in health harms as well as misperceptions about reduced nicotine content cigarettes and e-cigarettes.
Eligibility Criteria
You may qualify if:
- US resident age 18+
- Member of the partnering consumer research panel conducting the survey
- Non-smokers and tobacco cigarette smokers
You may not qualify if:
- Age less than 18
- Not a member of the partnering consumer research panel conducting the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Vermontlead
- National Institute on Drug Abuse (NIDA)collaborator
Study Sites (1)
University of Vermont
Burlington, Vermont, 05405, United States
Related Publications (1)
Villanti AC, Peasley-Miklus C, Mercincavage M, Mays D, Donny EC, Cappella JN, Strasser AA. Effect of nicotine corrective messaging on nicotine-related beliefs in US adults: a randomised controlled trial. Tob Control. 2025 Apr 1;34(2):162-168. doi: 10.1136/tc-2023-058252.
PMID: 37989586DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Andrea Villanti
- Organization
- Rutgers Center for Tobacco Studies
Study Officials
- PRINCIPAL INVESTIGATOR
Andrea C Villanti, PhD, MPH
University of Vermont
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 11, 2021
First Posted
March 18, 2021
Study Start
February 12, 2021
Primary Completion
May 31, 2021
Study Completion
May 31, 2021
Last Updated
December 2, 2022
Results First Posted
December 2, 2022
Record last verified: 2022-11
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- After completion of the study and publication of the primary findings, for a period up to 2 years.
- Access Criteria
- A data sharing agreement will be required for release of any data. Individuals requesting a copy of study data will need to submit a detailed research plan that includes the purpose of the proposed research, the variables required, the duration of the analysis phase, IRB approval with FWA information, investigator training in human subjects and other approvals specific to the individual datasets. They will also be required to submit a Data Protection Plan or Institutional Privacy Policy, describing the computing environment in which data will be managed and analyzed and how physical access to computing equipment will be controlled. Data will only be released once all IRB approvals and Human Subjects concerns have been addressed. The PI (A. Villanti) will be required to participate as an investigator on any project requiring data sharing.
De-identified participant data from study surveys will be made available upon request and according to access criteria after completion of the study and publication of primary findings.